WO2011029828A1 - Medicament container - Google Patents
Medicament container Download PDFInfo
- Publication number
- WO2011029828A1 WO2011029828A1 PCT/EP2010/063137 EP2010063137W WO2011029828A1 WO 2011029828 A1 WO2011029828 A1 WO 2011029828A1 EP 2010063137 W EP2010063137 W EP 2010063137W WO 2011029828 A1 WO2011029828 A1 WO 2011029828A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medicament container
- bag
- shape memory
- memory alloy
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
- A61M5/148—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons flexible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
- A61M11/008—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised by squeezing, e.g. using a flexible bottle or a bulb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0266—Shape memory materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0272—Electro-active or magneto-active materials
- A61M2205/0288—Electro-rheological or magneto-rheological materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
Definitions
- the invention relates to a medicament container for a liquid medicament, the medicament container comprising a bag with an outlet.
- medicaments have to be injected into the body. This applies in particular to medicaments, which are deactivated or have their efficiency remarkably decreased by oral administration, e.g. proteines (such as insulin, growth hormones and interferons), carbohydrates (e.g. heparin), antibodies and the majority of vaccines.
- proteines such as insulin, growth hormones and interferons
- carbohydrates e.g. heparin
- antibodies e.g. heparin
- medicaments are predominantly injected by means of syringes, medicament pens or medicament pumps.
- Some medicaments have to be administered by inhaling them from so called inhalers.
- WO 2009/069518 A1 discloses an inhaler, wherein the medicament to be inhaled is stored in a bag shaped medicament container.
- WO 02/058765 A1 discloses a drug delivery device which can be implanted in a patient.
- the drug delivery device includes a reservoir for the drug with at least one discharge outlet through which the drug can be discharged.
- a drive member comprising a shape memory alloy is arranged in the device in a deformed configuration to act against the reservoir directly or indirectly by recovering from its deformed configuration by virtue of its elastic properties to cause the volume of the reservoir available for the drug to be reduced and to cause drug in the reservoir to be
- DE 102 19 750 C1 discloses a medicament container for a liquid medicament, the medicament container comprising a deformable bag with an outlet and at least one deformation member consisting of a shape memory alloy and arranged to deform the deformable bag when the shape memory alloy passes from a first phase into a second phase by a phase transition, thereby changing the shape of the deformation member and squeezing a dose of the medicament through the outlet out of the bag.
- a medicament container for a liquid medicament comprises a deformable bag with an outlet and at least one deformation member consisting of a shape memory alloy.
- the at least one deformation member is arranged to deform the deformable bag when the shape memory alloy passes from a first phase into a second phase by a phase transition, thereby changing the shape of the deformation member and squeezing a dose of the medicament through the outlet out of the bag.
- the medicament container comprises several consecutive deformation members.
- Several independently actuatable deformation members provide a better control of delivery by emptying the bag incrementally by activating the deformation members one after the other. This is advantageous, for instance, when a medicament is to be administered in several consecutive doses.
- the deformable bag By means of a deformation member consisting of a shape memory alloy, the deformable bag can be deformed in a definite manner when the shape memory alloy passes from a first phase into a second phase. Arranging the deformation member appropriately, the deformation of the bag squeezes a dose of the medicament through the outlet out of the bag.
- the inventive design thereby allows pressing the medicament out without external displacing mechanisms like piston rods. Friction is avoided since no movable parts are required. Furthermore the invention allows for very lightweight, compact and cheap medicament containers.
- the medicament container comprises temperature regulation means for changing the temperature of a deformation member to cause the phase transition of its shape memory alloy. This allows to cause a change of the shape of a deformation member and a discharge of medicament by changing the temperature of a deformation member.
- the temperature regulation means may comprise electrical connections for each deformation member to connect it to an electrical power supply. This allows controlling the temperature of the deformation members in a simple and effective manner by means of electrical power.
- the shape memory alloy is a magnetic shape memory alloy. Phase transitions of such alloys changing them in shape or size can be induced by applied magnetic fields.
- the use of such alloys has the advantage that a phase transition caused by a magnetic field can be faster and more efficient than a
- the medicament container comprises preferably at least one magnetic field generator to generate a magnetic field to cause the phase transition of the magnetic shape memory alloy.
- At least one deformation member stretches out over at least part of a longitudinal extension of the bag. This allows deforming at least part of the bag by means of a deformation member.
- at least one defornnation nnennber is located at an outer surface of the bag. Such a location allows compressing the bag by constricting at least part of the bag by a deformation member located at its outer surface.
- at least one deformation member stretches out straightly in the first phase of its shape memory alloy and is rolled up spirally in the second phase of its shape memory alloy. Rolling up a deformation member in this manner, the deformable bag can be rolled up such that medicament is discharged through the outlet of the bag.
- this embodiment of the medicament container comprises a core around which the at least one deformation member is rolled up spirally in the second phase of its shape memory alloy.
- the core defines an axis around which the deformation member is rolled up and thereby controls and stabilizes advantageously the manner in which the deformation member is rolled up.
- the core avoids that a substantial amount of medicament remains inside the bag when the deformation member is rolled up, thereby improving the accuracy of the administration of a dose of the medicament and reducing the leftovers inside the bag after administration which is advantageous especially in the case of expensive medicaments.
- at least one deformation member stretches out as a helix around the bag, the radius of the helix being smaller in the second phase than in the first phase of the shape memory alloy.
- the bag is wrapped with a helix shaped deformation member and can be constricted and compressed by reducing the radius of the helix when the shape memory alloy passes from the first phase to the second phase, thereby discharging medicament through the outlet of the bag.
- this embodiment of the medicament container comprises a core stretching out over the axis of the helix.
- the core defines an axis around which the deformation member spirals and thereby controls and stabilizes advantageously the shrinking of the helix when the shape memory alloy passes from the first phase to the second phase. Furthermore the core avoids that a substantial amount of medicament remains inside the bag which provides the above mentioned advantages.
- the medicament container comprises several consecutive deformation members and preferably temperature regulation means or at least one magnetic field generator to cause phase transitions of the shape memory alloy of the deformation members independently of one another.
- Such an embodiment allows emptying the bag incrementally by activating the deformation members one after the other. This is advantageous, for instance, when a medicament is to be administered in several consecutive doses.
- the outlet may comprise an interface for receiving a hollow injection needle.
- the needle may be integrated with the medicament container.
- the medicament container may be part of an injection arrangement or an inhaler arrangement for delivering a liquid medicament to a human or an animal.
- the injection arrangement may comprise a valve and a hollow needle for piercing a patient's skin, the valve and needle being arranged at the outlet of the medicament container.
- a jet injector instead of the needle, a jet nozzle may be arranged.
- the medicament container may be used for delivering one of an analgesic, an anticoagulant, insulin, insulin derivate, heparin, Lovenox, a vaccine, a growth hormone, a peptide hormone, a protein, antibodies and complex carbohydrates.
- Figure 1 is a schematic lateral view of a medicament container comprising a deformable bag and a deformation member consisting of a shape memory alloy and stretching out straightly along a longitudinal axis of the bag in a first phase of the shape memory alloy,
- Figure 2 is a schematic lateral view of the medicament container of Fig. 1 in a second phase of the shape memory alloy in which the deformation member and the bag are rolled up spirally, and
- Figure 3 is a schematic lateral view of a medicament container comprising a deformable bag and several consecutive loops like deformation members consisting of a shape memory alloy, each deformation member winding once around the bag with a diameter depending on the phase of respective shape memory alloy.
- Figure 1 shows a schematic lateral view of a first embodiment of a medicament container 1 which is part of an injection arrangement I for delivering a liquid
- the medicament container 1 comprises an elongate deformable bag 2 with an outlet 3 and a deformation member 4.
- the deformation member 4 consists of a shape memory alloy and stretches out straightly along a longitudinal axis of the bag 2 in a first phase of the shape memory alloy.
- the deformation member 4 is located at an outer surface of the bag 2 and firmly attached to it.
- the bag 2 stores a liquid medicament.
- the outlet 3 is located at a first end 2.1 of the bag 2 which is fixed to a housing 5 for the medicament container 1 .
- the medicament container 1 comprises a rigid core 6 which is located at the outer surface of the outlet 3 at a side opposite to the side where the deformation member 4 is located and is firmly attached to the bag 2.
- the deformation member 4 is connected via electrical connections 7 to an electrical power supply through which electrical energy can be supplied to the deformation member 4 to cause a phase transition of the shape memory alloy.
- the injection arrangement I further comprises a hollow needle 8 for piercing a patient's skin.
- the needle 8 is connected to the outlet 3 so that the medicament can flow from the interior of the bag 2 through the outlet 3 to the needle 8.
- arrangement I shown in Fig. 1 further comprises an interface 9 for attaching the needle 8 to the outlet 3.
- the interface 9 may comprise a thread which has a mating thread in the housing 5.
- the needle 8 may be firmly attached to the housing 5 or the medicament container 1 without an interface 9.
- Figure 2 shows a schematic lateral view of the medicament container 1 in the injection arrangement I of Fig. 1 in a second phase of the shape memory alloy.
- the deformation member 4 is rolled up spirally from a second end meeting the second end 2.2 of the bag 2 to a first end meeting the first end 2.1 of the bag 2.
- the deformation member 4 spirals around the core 6 and thereby rolls up and compresses the bag 2 such that the medicament is squeezed out of the bag 2 through the outlet 3 towards the needle 8.
- the fixing of the first end 2.1 of the bag 2 to the housing 5 thereby serves to maintain the connection of the interior of the bag 2 to the outlet 3.
- the phase transition of the shape memory alloy from its first phase to its second phase is caused by supplying an amount of electrical energy to the deformation member 4 through the electrical connections 7 to sufficiently increase the temperature of the shape memory.
- Figure 3 shows a schematic lateral view of a second embodiment of a medicament container 1 in an injection arrangement I.
- the medicament container 1 comprises an elongate deformable bag 2 to store a liquid medicament, and a first end 2.1 of the bag 2 is fixed to a housing 5 of the bag 2 at an outlet 3 of the bag 2 connected to a needle 8.
- the medicament container 1 comprises several consecutive loop like deformation members 4 consisting of a shape memory alloy. Each deformation member 4 winds once around the bag 2 in a plane approximately orthogonal to a longitudinal axis of the bag 2.
- the medicament container 1 comprises a core 6 which extends out straightly and approximately parallel to this longitudinal axis from the first end 2.1 to a second end 2.2 of the bag 2.
- the core 6 may be located in the interior of the bag 2 or at an outer or inner surface of the bag 2. If it is located in the interior of the bag 2, it is arranged such that it does not lock up the outlet 3. If it is located at the outer surface of the bag 2, it is fed through all the loop like deformation members 4 so that each deformation member 4 winds around the core 6.
- a deformation member 4 has a first diameter D.
- a second diameter d which is smaller than the first diameter D.
- the medicament container 1 comprises temperature regulation means (not shown) to change the temperature of the consecutive deformation members 4 independently of one another.
- Such temperature regulation means may comprise electrical connections for each deformation member 4 to connect it to an electrical power supply to supply electrical energy to the deformation members 4 consecutively from the deformation member 4 nearest to the second end 2.2 of the bag 2 to the deformation member 4 nearest to the first end 2.1 of the bag 2.
- Fig. 3 shows an intermediate step of such a consecutive emptying of the bag 2 where a rearward portion of the bag 2 at its second end 2.2 has already been emptied by shrinking the corresponding deformation members 4, while the remaining part of the bag 2 is still filled with liquid medicament.
- the medicament container 1 may preferably be used for delivering one of an analgesic, an anticoagulant, insulin, insulin derivate, heparin, Lovenox, a vaccine, a growth hormone, a peptide hormone, a protein, antibodies and complex carbohydrates.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Vascular Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012528345A JP5701882B2 (ja) | 2009-09-10 | 2010-09-08 | 薬剤容器 |
| CA2772271A CA2772271A1 (en) | 2009-09-10 | 2010-09-08 | Medicament container |
| US13/391,736 US9180246B2 (en) | 2009-09-10 | 2010-09-08 | Medicament container |
| DK10750122.3T DK2475408T3 (en) | 2009-09-10 | 2010-09-08 | Drug container |
| EP10750122.3A EP2475408B1 (en) | 2009-09-10 | 2010-09-08 | Medicament container |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09169895 | 2009-09-10 | ||
| EP09169895.1 | 2009-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2011029828A1 true WO2011029828A1 (en) | 2011-03-17 |
Family
ID=41650454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2010/063137 Ceased WO2011029828A1 (en) | 2009-09-10 | 2010-09-08 | Medicament container |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9180246B2 (enExample) |
| EP (1) | EP2475408B1 (enExample) |
| JP (1) | JP5701882B2 (enExample) |
| CA (1) | CA2772271A1 (enExample) |
| DK (1) | DK2475408T3 (enExample) |
| WO (1) | WO2011029828A1 (enExample) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016174099A1 (en) * | 2015-04-28 | 2016-11-03 | Sanofi-Aventis Deutschland Gmbh | Flexible container for an injection device |
| DE102017114930A1 (de) * | 2017-07-04 | 2019-01-10 | Eto Magnetic Gmbh | Ausstoßvorrichtung |
| US20240350729A1 (en) * | 2021-08-17 | 2024-10-24 | Ag Ip Holding Llc | Pump device |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003068290A2 (en) | 2002-02-11 | 2003-08-21 | Antares Pharma, Inc. | Intradermal injector |
| WO2006079064A1 (en) | 2005-01-24 | 2006-07-27 | Antares Pharma, Inc. | Prefilled needle assisted jet injector |
| WO2007131013A1 (en) | 2006-05-03 | 2007-11-15 | Antares Pharma, Inc. | Two-stage reconstituting injector |
| US9144648B2 (en) | 2006-05-03 | 2015-09-29 | Antares Pharma, Inc. | Injector with adjustable dosing |
| ES2548447T3 (es) | 2008-03-10 | 2015-10-16 | Antares Pharma, Inc. | Dispositivo de seguridad para inyector |
| CA2723291C (en) * | 2008-05-14 | 2017-08-15 | Becton, Dickinson And Company | Separatable infusion set with cleanable interface and straight line attachment |
| JP5611208B2 (ja) | 2008-08-05 | 2014-10-22 | アンタレス・ファーマ・インコーポレーテッド | 多数回服用量の注射装置 |
| EP2376142B1 (en) | 2009-01-12 | 2018-06-20 | Becton, Dickinson and Company | Infusion set and/or patch pump having at least one of an in-dwelling rigid catheter with flexible features and/or a flexible catheter attachment |
| US8579865B2 (en) | 2009-03-20 | 2013-11-12 | Antares Pharma, Inc. | Hazardous agent injection system |
| US8795230B2 (en) | 2010-11-30 | 2014-08-05 | Becton, Dickinson And Company | Adjustable height needle infusion device |
| US8784383B2 (en) | 2010-11-30 | 2014-07-22 | Becton, Dickinson And Company | Insulin pump dermal infusion set having partially integrated mechanized cannula insertion with disposable activation portion |
| US8814831B2 (en) | 2010-11-30 | 2014-08-26 | Becton, Dickinson And Company | Ballistic microneedle infusion device |
| US9950109B2 (en) | 2010-11-30 | 2018-04-24 | Becton, Dickinson And Company | Slide-activated angled inserter and cantilevered ballistic insertion for intradermal drug infusion |
| US8795234B2 (en) | 2010-11-30 | 2014-08-05 | Becton, Dickinson And Company | Integrated spring-activated ballistic insertion for drug infusion device |
| US9220660B2 (en) | 2011-07-15 | 2015-12-29 | Antares Pharma, Inc. | Liquid-transfer adapter beveled spike |
| US8496619B2 (en) | 2011-07-15 | 2013-07-30 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
| EP4327849A3 (en) | 2012-03-06 | 2024-04-24 | Antares Pharma, Inc. | Prefilled syringe with breakaway force feature |
| KR20150011346A (ko) | 2012-04-06 | 2015-01-30 | 안타레스 팔마, 인코퍼레이티드 | 테스토스테론 조성물의 바늘-보조식 젯 주입 투여 장치 및 방법 |
| USD687536S1 (en) | 2012-04-13 | 2013-08-06 | Becton, Dickinson And Company | Infusion device |
| USD687141S1 (en) | 2012-04-13 | 2013-07-30 | Becton, Dickinson And Company | Infusion device |
| USD685083S1 (en) | 2012-04-13 | 2013-06-25 | Becton, Dickinson And Company | Infusion device |
| USD685084S1 (en) | 2012-04-13 | 2013-06-25 | Becton, Dickinson And Company | Infusion device |
| USD687140S1 (en) | 2012-04-13 | 2013-07-30 | Becton, Dickinson And Company | Infusion device |
| USD688784S1 (en) | 2012-04-13 | 2013-08-27 | Becton, Dickinson And Company | Infusion device |
| WO2013169800A1 (en) | 2012-05-07 | 2013-11-14 | Antares Pharma, Inc. | Injection device with cammed ram assembly |
| DK2953667T3 (da) | 2013-02-11 | 2020-01-27 | Antares Pharma Inc | Nålestøttet jetinjektionsindretning med reduceret udløserkraft |
| EP3572108A1 (en) | 2013-03-11 | 2019-11-27 | Antares Pharma, Inc. | Dosage injector with pinion system |
| WO2014165136A1 (en) | 2013-03-12 | 2014-10-09 | Antares Pharma, Inc. | Constant volume prefilled syringes and kits thereof |
| CN105748090A (zh) * | 2016-02-02 | 2016-07-13 | 上海交通大学 | 一种基于mems微针的微创采样/注射装置 |
| DE102016003599A1 (de) | 2016-03-27 | 2017-09-28 | Eto Magnetic Gmbh | Elektrischer linearer repetitiver Impulsantrieb |
| CN109310820B (zh) * | 2016-04-21 | 2021-06-11 | 赛诺菲-安万特德国有限公司 | 用于液体药剂的容器 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002058765A1 (en) | 2001-01-27 | 2002-08-01 | Krumme John F | A drug delivery device |
| DE10219750C1 (de) | 2002-05-02 | 2003-07-24 | Siemens Ag | Vorrichtung zur Zufuhr von fließfähigen oder pastösen Substanzen |
| WO2009069518A1 (ja) | 2007-11-29 | 2009-06-04 | Japan Tobacco Inc. | エアロゾル吸引システム |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4088166A (en) * | 1974-11-21 | 1978-05-09 | Baxter Travenol Laboratories, Inc. | Molded collapsible solution container having gusset portions |
| US4136802A (en) * | 1977-09-21 | 1979-01-30 | The Continental Group, Inc. | Spray dispenser with spring biased flexible container |
| US4192308A (en) * | 1977-10-25 | 1980-03-11 | Alza Corporation | Device using prestretched polymer for dispensing medication |
| JPH077964Y2 (ja) * | 1992-06-22 | 1995-03-01 | 石塚硝子株式会社 | 輸液用プラスチック容器 |
| US5685456A (en) * | 1995-05-24 | 1997-11-11 | The United States Of America As Represented By The Secretary Of The Navy | Regulated dispensing system |
| JPH09193948A (ja) * | 1996-01-19 | 1997-07-29 | Yoshiteru Miyama | チューブ |
| DE19733278C2 (de) * | 1997-08-01 | 1999-11-11 | Storz Endoskop Gmbh | Druckbehälter zum Beaufschlagen eines in diesem aufgenommenen, mit einer medizinischen Flüssigkeit gefüllten flexiblen Beutels mit Druck |
| PE20010720A1 (es) * | 1999-12-11 | 2001-07-26 | Glaxo Group Ltd | Distribuidor de medicamento |
| JP2004528151A (ja) * | 2001-06-11 | 2004-09-16 | グラクソ グループ リミテッド | 薬剤ディスペンサ |
| JP3615161B2 (ja) * | 2001-07-09 | 2005-01-26 | 櫻護謨株式会社 | 光硬化性中空構造物及びその硬化方法 |
| US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
| JP5008864B2 (ja) * | 2005-12-06 | 2012-08-22 | 藤森工業株式会社 | 薬液収納容器 |
-
2010
- 2010-09-08 WO PCT/EP2010/063137 patent/WO2011029828A1/en not_active Ceased
- 2010-09-08 US US13/391,736 patent/US9180246B2/en active Active
- 2010-09-08 JP JP2012528345A patent/JP5701882B2/ja not_active Expired - Fee Related
- 2010-09-08 DK DK10750122.3T patent/DK2475408T3/en active
- 2010-09-08 CA CA2772271A patent/CA2772271A1/en not_active Abandoned
- 2010-09-08 EP EP10750122.3A patent/EP2475408B1/en not_active Not-in-force
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002058765A1 (en) | 2001-01-27 | 2002-08-01 | Krumme John F | A drug delivery device |
| DE10219750C1 (de) | 2002-05-02 | 2003-07-24 | Siemens Ag | Vorrichtung zur Zufuhr von fließfähigen oder pastösen Substanzen |
| WO2009069518A1 (ja) | 2007-11-29 | 2009-06-04 | Japan Tobacco Inc. | エアロゾル吸引システム |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016174099A1 (en) * | 2015-04-28 | 2016-11-03 | Sanofi-Aventis Deutschland Gmbh | Flexible container for an injection device |
| US11224690B2 (en) | 2015-04-28 | 2022-01-18 | Sanofi-Aventis Deutschland Gmbh | Flexible container for an injection device |
| DE102017114930A1 (de) * | 2017-07-04 | 2019-01-10 | Eto Magnetic Gmbh | Ausstoßvorrichtung |
| US20240350729A1 (en) * | 2021-08-17 | 2024-10-24 | Ag Ip Holding Llc | Pump device |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2475408A1 (en) | 2012-07-18 |
| US9180246B2 (en) | 2015-11-10 |
| EP2475408B1 (en) | 2015-02-18 |
| CA2772271A1 (en) | 2011-03-17 |
| DK2475408T3 (en) | 2015-05-26 |
| US20120291778A1 (en) | 2012-11-22 |
| JP2013504348A (ja) | 2013-02-07 |
| JP5701882B2 (ja) | 2015-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2475408B1 (en) | Medicament container | |
| US6656159B2 (en) | Dispenser for patient infusion device | |
| JP6224745B2 (ja) | 可撓性および共形性を有するパッチポンプ | |
| US6723072B2 (en) | Plunger assembly for patient infusion device | |
| EP2675499B1 (en) | Manual basal bolus drug delivery device | |
| JP2013504348A5 (enExample) | ||
| CN106512149B (zh) | 一种气动无针注射器 | |
| US4687468A (en) | Implantable insulin administration device | |
| US20040078028A1 (en) | Plunger assembly for patient infusion device | |
| US20030199824A1 (en) | Dispenser for patient infusion device | |
| US20040153032A1 (en) | Dispenser for patient infusion device | |
| AU2009202856A1 (en) | Hydraulically actuated pump for long duration medicament adminstration | |
| JP2004528137A (ja) | 大容量ボーラス装置および方法 | |
| JP2002517287A (ja) | 患者制御薬品投与装置 | |
| US20090036867A1 (en) | Medication Delivery Device Applying A Collapsible Reservoir | |
| EP2470242A2 (en) | Medicament container | |
| CN115089807A (zh) | 一种植入式给药系统 | |
| AU6956991A (en) | Self-driven pump device | |
| CA1238830A (en) | Implantable insulin administration device | |
| EP2473218B1 (en) | Medicament container | |
| AU2010288580A1 (en) | Medicament container | |
| CN2363718Y (zh) | 自控安全镇痛装置 | |
| JP2552692B2 (ja) | 薬剤供給装置 | |
| KR101277628B1 (ko) | 주사기용 바늘 | |
| US20170095610A1 (en) | Personal injection device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10750122 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2772271 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012528345 Country of ref document: JP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2010750122 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13391736 Country of ref document: US |